Get the Stockscreener App
0.731
7.44%
-0.069
After Hours:
.74
0.009
+1.23%
Maxcyte Inc stock is traded at $0.731, with a volume of 879.17K.
It is down -7.44% in the last 24 hours and up +9.07% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$0.80
Open:
$0.7967
24h Volume:
879.17K
Relative Volume:
0.84
Market Cap:
$77.98M
Revenue:
$34.42M
Net Income/Loss:
$-45.63M
P/E Ratio:
-1.7008
EPS:
-0.4298
Net Cash Flow:
$-41.23M
1W Performance:
-8.30%
1M Performance:
+9.07%
6M Performance:
-54.29%
1Y Performance:
-76.79%
1-Day Range:
$0.731
$0.8106
1-Week Range:
$0.7401
$0.8731
52-Week Range:
$0.6434
$3.30
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.731 | 86.51M | 34.42M | -45.63M | -41.23M | -0.4298 |
|
ABT
Abbott Laboratories
|
108.47 | 191.06B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.81 | 133.77B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.21 | 113.29B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.28 | 103.56B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.61 | 48.53B | 6.07B | 1.06B | 1.34B | 1.8063 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-22-25 | Initiated | Stephens | Overweight |
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
Buybacks Report: What is the next catalyst for MaxCyte Inc2026 Big Picture & Verified Trade Idea Suggestions - baoquankhu1.vn
Mirabella Financial Services LLP Purchases 1,600,000 Shares of MaxCyte, Inc. $MXCT - MarketBeat
MaxCyte (MXCT) Projected to Post Earnings on Tuesday - Defense World
MaxCyte (NASDAQ:MXCT) Stock Rating Upgraded by Wall Street Zen - Defense World
Risk Check: Should I average down on MaxCyte Inc stock2026 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Insider Sell: Will MaxCyte Inc outperform tech stocksInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn
MaxCyte unveils new 96-well electroporation platform to accelerate discovery - Select Science
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Why MaxCyte Inc. stock attracts high net worth investorsBuy Signal & Intraday High Probability Setup Alerts - Naître et grandir
Options Flow: Can MaxCyte Inc sustain its profitabilityJuly 2025 Fed Impact & Safe Capital Growth Stock Tips - baoquankhu1.vn
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Update - MarketBeat
Free cash flow per share of MaxCyte, Inc. – FWB:MYE0 - TradingView
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Analysts - MarketBeat
MaxCyte, Inc.Common Stock (NQ: MXCT - The Chronicle-Journal
MaxCyte unveils ExPERT DTx, a 96-well electroporation platform to accelerate discovery - marketscreener.com
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery - Finviz
Insider Buy: Is MaxCyte Inc trading at a discountJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - The Manila Times
New MaxCyte lab device runs 96 cell samples in a three-minute cycle - Stock Titan
MXCT | MaxCyte, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - The Manila Times
MaxCyte, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - Quiver Quantitative
MaxCyte schedules March 24 call on 2025 results for 4:30 p.m. ET - Stock Titan
MXCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Market Leaders: What is BEDUs book value per shareWeekly Volume Report & Long-Term Growth Stock Strategies - baoquankhu1.vn
Take Profit: Is MaxCyte Inc a momentum stockJuly 2025 PostEarnings & Capital Protection Trading Alerts - baoquankhu1.vn
What are MaxCyte Inc.’s recent SEC filings showingMarket Activity Recap & Daily Profit Focused Stock Screening - mfd.ru
Dividend Watch: Is MaxCyte Inc forming a breakout patternWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Day Trade: Will MaxCyte Inc benefit from rising consumer demand2025 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
Cadian Capital discloses 3.5% MaxCyte (MXCT) stake in latest 13G/A - Stock Titan
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January - MarketBeat
Is MaxCyte Inc. being accumulated by smart money2025 Institutional Moves & Daily Market Momentum Tracking - mfd.ru
Will MaxCyte Inc. stock outperform Nasdaq indexJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
Is MaxCyte Inc. stock gaining market shareTreasury Yields & Short-Term High Return Ideas - mfd.ru
Capricorn Fund Managers Ltd Acquires 8,200,000 Shares in MaxCyte Inc - GuruFocus
Is MaxCyte Inc. stock a value trapJuly 2025 Review & Real-Time Stock Movement Alerts - mfd.ru
Will MaxCyte Inc. benefit from rising consumer demandBond Market & Community Trade Idea Sharing - mfd.ru
Brokerages Set MaxCyte, Inc. (NASDAQ:MXCT) PT at $7.00 - Defense World
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen - MarketBeat
Capricorn Fund takes 7.7% stake in MaxCyte (NASDAQ: MXCT) - Stock Titan
MaxCyte (NASDAQ:MXCT) Stock Price Down 4.2%Here's Why - MarketBeat
Sentiment Recap: Can ATGL grow without dilutionQuarterly Growth Report & Technical Entry and Exit Tips - baoquankhu1.vn
MaxCyte team building boosts morale at sales meeting - Traders Union
Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn
Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru
Hedge Fund Bets: Is Algoma Steel Group Inc benefiting from interest rate changesMarket Performance Recap & High Return Stock Watch Alerts - baoquankhu1.vn
Rally Mode: Is MaxCyte Inc showing insider buyingTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Portfolio Shifts: What is the next catalyst for MaxCyte IncFed Meeting & Breakout Confirmation Alerts - baoquankhu1.vn
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.64%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):